Systemic Inflammation and Its Response to Treatment in Patients With Asthma

References

1. 1.↵
   1. Jousilahti PSV,
   2. Hakala K,
   3. Rasi V,
   4. Vahtera E,
   5. Palosuo T

   . The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 2002;89(4):381–385.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Olafsdottir IS,
   2. Gislason T,
   3. Thjodleifsson B,
   4. Olafsson I,
   5. Gislason D,
   6. Jogi R,
   7. Janson C

   . C-reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax 2005;60(6):451–454.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Takemura M,
   2. Matsumoto H,
   3. Nilmi A,
   4. Ueda T,
   5. Matsuoka H,
   6. Yamaguchi M,
   7. et al

   . High sensitivity C-reactive protein in asthma. Eur Respir J 2006;27(5):908–912.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   Global Initiative for Asthma (GINA); National Heart, Lung and Blood Institute (NHLBI). Global strategy for asthma management and prevention. Bethesda, MD; Updated 2010. http://www.ginasthma.com/Guidelineitem.asp??l1=2&l2=1&intId=60. Accessed April 11, 2011.
5. 5.↵
   1. Enright P,
   2. Ward BJ,
   3. Tracy RP,
   4. Lasser EC

   . Asthma and its association with cardiovascular disease in the elderly. J Asthma 1996;33(1):45–53.

   OpenUrlPubMedWeb of Science
6. 6.
   1. Tracy RP

   . Inflammation in cardiovascular disease: cart, horse, or both? (editorial). Circulation 1998;97(20):2000–2002.

   OpenUrlFREE Full Text
7. 7.
   1. Rifai N,
   2. Tracy RP,
   3. Ridker PM

   . Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999;45(12):2136–2141.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Roberts WL,
   2. Sedrick R,
   3. Moulton L,
   4. Spencer A,
   5. Rifai N

   . Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 2000;46(4):461–468.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Roberts WL,
   2. Moulton L,
   3. Law TC,
   4. Farrow G,
   5. Cooper-Anderson M,
   6. Savory J,
   7. Rifai N

   . Evaluation of nine automated high sensitivity C-reactive protein methods: Implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47(3):418–425.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Kony S,
    2. Zureik M,
    3. Driss F,
    4. Neukirch C,
    5. Leynaert B,
    6. Neukirch F

    . Association of bronchial hyperresponsiveness and lung function with C - reactive protein (CRP): a population based study. Thorax 2004;59(10):892–896.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Knudson RJ,
    2. Lebowitz MD,
    3. Holberg CJ,
    4. Burrows B

    . Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127(6):725–734.

    OpenUrlPubMedWeb of Science
12. 12.↵
    1. Pradhan AD,
    2. Manson JE,
    3. Rifai N,
    4. Buring JE,
    5. Ridker PM

    . C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286(3):327–334.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.
    1. Visser M,
    2. Bouter LM,
    3. McQuillen GM,
    4. Wener MH,
    5. Harris TB

    . Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282(22):2131–2135.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.
    1. Yudkin JS,
    2. Stehouwer CDA,
    3. Emeis JJ,
    4. Coppack SW

    . C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:(4):972–978.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Earl SF

    . Asthma, body mass index, and C-reactive protein among US adults. J Asthma 2003;40(7):733–739.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Hernández Velásquez L,
    2. Segura Méndez NH

    . Relation between asthma severity and body mass index. Case series. Rev Alerg Mex 2007;54(4):107–110.

    OpenUrlPubMed
17. 17.↵
    1. Boulet LP,
    2. Franssen E

    . Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007;101(11):2240–2247.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Maniscalco M,
    2. Zedda A,
    3. Faraone S,
    4. Cerbone MR,
    5. Cristiano S,
    6. Giardiello C,
    7. Sofia M

    . Weight loss and asthma control in severely obese asthmatic females. Respir Med 2008;102(1):102–128.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Sin DD,
    2. Lacy P,
    3. York E,
    4. Man SF

    . Effects of fluticasone on systemic markers of inflammation in COPD. Am J Respir Crit Care Med 2004;170(7):760–765.

    OpenUrlCrossRefPubMedWeb of Science